Airway compression in a neonate with thyroid dyshormonogenesis due to SLC26A7 defect
SLC26A7 encodes an apical iodide transporter in thyroid follicular cells and causes, when mutated, congenital hypothyroidism (CH). We report a patient diagnosed with goitrous CH, who initially presented with neck enlargement and inspiratory stridor on day 3 of life. Levothyroxine therapy resulted in prompt improvement in upper airway compression, and surgical interventions were avoided. The levothyroxine dosage per body weight was gradually reduced to 0.5 μg/kg/day by age 11 months. Genomic sequencing of CH-related genes identified compound heterozygous protein-truncating SLC26A7 variants: c.612_613dup, p.Ser207Tyrfs*31 and c.1498C>T, p.Gln500*. We emphasize the importance of considering genetic etiologies in cases of neonatal goiter with upper airway compression, particularly in the absence of exposure to excessive iodine or antithyroid drugs.
Authors
- Y. Hirano (ORCID: https://orcid.org/0009-0003-1789-3431)
- Satoshi Narumi (ORCID: https://orcid.org/0000-0002-0940-4517)
- Marie Mitani‐Konno
- Kazuhiro Shimura (ORCID: https://orcid.org/0000-0002-9797-5925)
- Tomonobu Hasegawa (ORCID: https://orcid.org/0000-0002-0143-3989)
- Naoya Fukushima (ORCID: https://orcid.org/0000-0003-3255-7527)
Institutions
- Keio University (JP)
- Hiratsuka City Hospital (JP)
- Kitakashiwa Rehabilitation General Hospital (JP)
- Chiba Hospital (JP)
- Yokohama Municipal Citizen's Hospital (JP)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1093/ejendo/lvaf198
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- JCR Pharmaceuticals
- Novo Nordisk
- Novo Nordisk Pharma
- Japan Society for the Promotion of Science